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Background
To determine significance of patient-prosthesis mismatch
(PPM) (indexed effective orifice area < 1,2 cm²/m²) after
isolated mitral valve replacement(MVR) in pts with small
cavity of left ventricle (SCLV) (end-diastolic volume
(EDV) ≤ 75 ml) during hospital period.
Materials
1811 adult patients (pts) with isolated mitral valve disease
MVR were operated in Institute from 01.01.2000 till
01.01.2007. There were 127 (7,0%) pts with SCLV. Among
them 48(37,8%) males and 79(62,2%) females in average
age 53,2+7,1 yy. 110 (86,6%) pts belonged to IV NYHA
class of heart failure, 17 (13,4%) – to III. Previous closed
mitral comissurotomy was performed in 31 (24,4%) pts, to
7 pts – twice (closed recomissirothomy). Average body
surface area (BSA) was 1,87±0,32 m². Following prostheses
were implanted: bileaflet (Saint Jude, Carbomedics, On-X,
Edwards-Mira) (n = 88) and monodisc as Alcarbon`s type
(MIKS, LIKS) (n = 40). Following prosthesis sizes were
used: 23 mm (n = 1), 25 mm (n = 74), 26 mm (n = 3),
27 mm (n = 49).
Results
Hospital mortality (HM) was 5,5% (n = 7). It was higher
in cases with 27 mm size of implanted prosthesis - 8,2%
(n = 4/49) than in other group - 3,8% (n = 3/78)
(p<0,01). PPM were marked in 21 (16,5%) pts with BSA
>1,75 m² and size of prothesis 25 mm but there were
no influence on HM. Heart failure and PPM were
marked in 5 (3,9%) pts with BSA > 1,75 m², size of
prothesis 25 mm and cavity of LV (EDV ≤ 50 ml). Risk-
factors for PPM in SCLV group of pts on hospital stage
were: small cavity of LV (EDV ≤ 50 ml) especially in pts
with BSA > 1,75 m², previous operation, pulmonary
hypertension, mitral valve calcification 3+, duration of
rheumatic disease ≥ 25 years.
Conclusion
Pts with SCLV are in group of higher risk for operation
and increasing risk of PPM. In these cases implantation
of 25 mm prosthesis is expedient, but for pts with EDV
50 ml and BSA > 1,75 m² it may lead for significant
PPM and heart failure. 23 mm prosthesis may use in pts
with body mass ≤ 45 kg (BSA < 1,5 m²).
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